iSpecimen (NASDAQ:ISPC) Announces Earnings Results

iSpecimen (NASDAQ:ISPC) released its earnings results on Monday. The company reported ($6.28) earnings per share for the quarter, Zacks reports. iSpecimen had a negative return on equity of 139.25% and a negative net margin of 91.66%.

iSpecimen Trading Up 4.1 %

ISPC traded up $0.05 during midday trading on Monday, hitting $1.27. 18,724 shares of the company were exchanged, compared to its average volume of 420,018. The company’s 50 day simple moving average is $1.53 and its 200 day simple moving average is $2.94. The firm has a market capitalization of $1.22 million, a price-to-earnings ratio of -0.07 and a beta of 1.77. iSpecimen has a 1-year low of $1.02 and a 1-year high of $11.80.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.